HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thrombotic occlusion of the common carotid artery (CCA) in acute ischemic stroke treated with intravenous tissue plasminogen activator (TPA).

Abstract
Although common carotid artery (CCA) occlusions are rare, acute clinical presentations vary from mild to devastating strokes primarily due to tandem occlusions in the intracranial arteries. Three patients with acute CCA occlusions were treated with systemic tissue plasminogen activator (TPA). Blood pressures were kept at the upper limits allowed with TPA therapy with fluid balance and the 'head-down' position. Recanalization occurred in intracranial vessels only. Marked early neurological improvement occurred in two of three patients. CCA occlusions should not be considered contra-indication to systemic thrombolysis.
AuthorsV K Sharma, G Tsivgoulis, A Y Lao, M Flaster, J L Frey, M D Malkoff, A V Alexandrov
JournalEuropean journal of neurology (Eur J Neurol) Vol. 14 Issue 2 Pg. 237-40 (Feb 2007) ISSN: 1468-1331 [Electronic] England
PMID17250737 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Fibrinolytic Agents
  • Tissue Plasminogen Activator
Topics
  • Acute Disease
  • Aged
  • Aged, 80 and over
  • Angiography, Digital Subtraction
  • Brain Ischemia (etiology)
  • Carotid Artery Thrombosis (complications, diagnosis, drug therapy)
  • Carotid Artery, Common
  • Cerebral Angiography
  • Female
  • Fibrinolytic Agents (therapeutic use)
  • Humans
  • Male
  • Nervous System (drug effects, physiopathology)
  • Recovery of Function
  • Stroke (etiology, physiopathology)
  • Tissue Plasminogen Activator (therapeutic use)
  • Tomography, X-Ray Computed
  • Treatment Outcome
  • Ultrasonography, Doppler, Duplex

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: